Atlas Trials

Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma

Clinical trial NCT03471897 · COMPLETED

Trial details

NCT number
NCT03471897
Sponsor
Chalmers University of Technology
Status
COMPLETED
Study type
OBSERVATIONAL
Renal Cell Carcinoma
Start date
2016-04-28
Primary completion
2017-10-25
Enrollment
237

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.